6-K 1 dp107351_6k.htm FORM 6-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May, 2019

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X

  Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes   No

X

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes   No

X

 

 

 

ISRAEL CHEMICALS LTD.

 

INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of Israel Chemicals Ltd. filed with the Israel Securities Authority and dated March 4, 2019 (Filing Number: 2019-02-018507) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

ISRAEL CHEMICALS LTD.

 

1.Results of the Extraordinary General Meeting of Shareholders

 

 

 

Item 1

 

Results of the Extraordinary General Meeting of Shareholders

 

Further to the notice of the Extraordinary General Meeting of shareholders on Form 6-K dated April 18, 2019 (Accession no. 0000950103-19-004895), as updated by the report on Form 6-K dated May 20, 2019 (Accession no. 0000950103-19-006556), the Company hereby reports that all items on the agenda of the Extraordinary General Meeting that was held today, May 29, 2019, which are listed below, were approved:

 

1.Election of Mr. Yoav Doppelt as a director, effective as of the date of this meeting.

 

2.Approval of the compensation terms and equity grant for our new Executive Chairman of the Board, Mr. Doppelt.

 

3.Approval of a Special Bonus for 2018 to our Executive Chairman of the Board, Mr. Johanan Locker.

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Israel Chemicals Ltd.
     
      By: /s/ Kobi Altman
        Name: Kobi Altman
        Title: Chief Financial Officer

 

    Israel Chemicals Ltd.
     
      By: /s/ Aya Landman
        Name: Aya Landman
        Title: Global Company Secretary

 

Date: May 29, 2019